Analyst Ratings For Teva Pharmaceutical Industries (NYSE:TEVA)
Today, Maxim Group reiterated its Hold rating on Teva Pharmaceutical Industries (NYSE:TEVA).
Some recent analyst ratings include
- 3/1/2018-Maxim Group Reiterated Rating of Hold.
- 2/13/2018-Wells Fargo & Co Reiterated Rating of Sell.
- 2/11/2018-Credit Suisse Group Upgrade from a “Neutral ” rating to a ” Outperform” rating.
- 2/9/2018-Gabelli was Downgraded by analysts at Gabelli from a “Buy ” rating to a ” Hold” rating. They now have a $19.00 price target on the stock.
Dividend information for Teva Pharmaceutical Industries (NYSE:TEVA)
Teva Pharmaceutical Industries (NYSE:TEVA) pays an annual dividend of $0.72 with a yield of 3.90% and an average dividend growth of -14.40% based on a 3 Year Average..
Dividend History for Teva Pharmaceutical Industries (NYSE:TEVA)
- On 11/2/2017 Teva Pharmaceutical Industries announced a quarterly dividend of $0.09 2.74% with an ex dividend date of 11/27/2017 which will be payable on 12/12/2017.
- On 8/7/2017 Teva Pharmaceutical Industries announced a quarterly dividend of $0.09 1.83% with an ex dividend date of 8/25/2017 which will be payable on 9/14/2017.
- On 5/11/2017 Teva Pharmaceutical Industries announced a quarterly dividend of $0.34 4.28% with an ex dividend date of 6/1/2017 which will be payable on 6/22/2017.
- On 2/13/2017 Teva Pharmaceutical Industries announced a quarterly dividend of $0.34 3.7% with an ex dividend date of 2/28/2017 which will be payable on 3/20/2017.
- On 11/15/2016 Teva Pharmaceutical Industries announced a quarterly dividend of $0.34 with an ex dividend date of 12/1/2016 which will be payable on 12/20/2016.
- On 8/4/2016 Teva Pharmaceutical Industries announced a quarterly dividend of $0.34 with an ex dividend date of 8/18/2016 which will be payable on 9/8/2016.
- On 5/9/2016 Teva Pharmaceutical Industries announced a quarterly dividend of $0.34 with an ex dividend date of 5/20/2016 which will be payable on 6/7/2016.
Recent Insider Trading Activity For Teva Pharmaceutical Industries (NYSE:TEVA)
Teva Pharmaceutical Industries (NYSE:TEVA) has insider ownership of 7.10% and institutional ownership of 49.99%.
- On 2/15/2018 Mark Sabag, EVP, sold 5,050 with an average share price of $19.68 per share and the total transaction amounting to $99,384.00.
Recent Trading Activity for Teva Pharmaceutical Industries (NYSE:TEVA)
Shares of Teva Pharmaceutical Industries closed the previous trading session at 18.68 down -0.04 0.21% with 18.709999084472656 shares trading hands.